These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32706388)

  • 1. Improving the analytical toolbox to investigate copurifying host cell proteins presence: N-(4)-(β-acetylglucosaminyl)- l-asparaginase case study.
    Clavier S; Fougeron D; Petrovic S; Elmaleh H; Fourneaux C; Bugnazet D; Duffieux F; Masiero A; Mitra-Kaushik S; Genet B; Fromentin Y; Kreiss P; Laborderie B; Brault D; Menet JM
    Biotechnol Bioeng; 2020 Nov; 117(11):3368-3378. PubMed ID: 32706388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.
    Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR
    Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA.
    Gunawan F; Nishihara J; Liu P; Sandoval W; Vanderlaan M; Zhang H; Krawitz D
    Biotechnol Bioeng; 2018 Feb; 115(2):382-389. PubMed ID: 28986978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved detection of host cell proteins (HCPs) in a mammalian cell-derived antibody drug using liquid chromatography/mass spectrometry in conjunction with an HCP-enrichment strategy.
    Thompson JH; Chung WK; Zhu M; Tie L; Lu Y; Aboulaich N; Strouse R; Mo WD
    Rapid Commun Mass Spectrom; 2014 Apr; 28(8):855-60. PubMed ID: 24623688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
    Huang Y; Molden R; Hu M; Qiu H; Li N
    J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
    Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
    J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis.
    Madsen JA; Farutin V; Carbeau T; Wudyka S; Yin Y; Smith S; Anderson J; Capila I
    MAbs; 2015; 7(6):1128-37. PubMed ID: 26291024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.
    Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J
    MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-Asparaginase and HCP quantification by SWATH LC-MS/MS for new and improved purification step in Erwinia chrysanthemil-asparaginase manufacture.
    Modi T; Regufe da Mota S; Gervais D
    J Pharm Biomed Anal; 2022 Feb; 209():114537. PubMed ID: 34929569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced mass spectrometry workflows for accurate quantification of trace-level host cell proteins in drug products: Benefits of FAIMS separation and gas-phase fractionation DIA.
    Beaumal C; Beck A; Hernandez-Alba O; Carapito C
    Proteomics; 2023 Aug; 23(16):e2300172. PubMed ID: 37148167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A highly sensitive and robust LC-MS platform for host cell protein characterization in biotherapeutics.
    Ji Q; Sokolowska I; Cao R; Jiang Y; Mo J; Hu P
    Biologicals; 2023 May; 82():101675. PubMed ID: 37028215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated strategy for deep profiling of host cell proteins in downstream processing of therapeutic monoclonal antibodies: Novel approach to isolate and digest host cell proteins.
    Zarei M; Jonveaux J; Razvi A; Jahn M
    Eur J Pharm Biopharm; 2024 Aug; 201():114369. PubMed ID: 38885909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical advancement and practical considerations of LC-MS/MS-based methods for host cell protein identification and quantitation to support process development.
    Guo J; Kufer R; Li D; Wohlrab S; Greenwood-Goodwin M; Yang F
    MAbs; 2023; 15(1):2213365. PubMed ID: 37218066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development.
    E SY; Hu Y; Molden R; Qiu H; Li N
    J Pharm Sci; 2023 Mar; 112(3):673-679. PubMed ID: 36220394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host cell protein quantification of an optimized purification method by mass spectrometry.
    Reiter K; Suzuki M; Olano LR; Narum DL
    J Pharm Biomed Anal; 2019 Sep; 174():650-654. PubMed ID: 31279895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host cell protein testing by ELISAs and the use of orthogonal methods.
    Zhu-Shimoni J; Yu C; Nishihara J; Wong RM; Gunawan F; Lin M; Krawitz D; Liu P; Sandoval W; Vanderlaan M
    Biotechnol Bioeng; 2014 Dec; 111(12):2367-79. PubMed ID: 24995961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development.
    Molden R; Hu M; Yen E S; Saggese D; Reilly J; Mattila J; Qiu H; Chen G; Bak H; Li N
    MAbs; 2021; 13(1):1955811. PubMed ID: 34365906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring process-related impurities in biologics-host cell protein analysis.
    Pilely K; Johansen MR; Lund RR; Kofoed T; Jørgensen TK; Skriver L; Mørtz E
    Anal Bioanal Chem; 2022 Jan; 414(2):747-758. PubMed ID: 34595561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast, Robust, and Sensitive Identification of Residual Host Cell Proteins in Recombinant Monoclonal Antibodies Using Sodium Deoxycholate Assisted Digestion.
    Li D; Farchone A; Zhu Q; Macchi F; Walker DE; Michels DA; Yang F
    Anal Chem; 2020 Sep; 92(17):11888-11894. PubMed ID: 32786500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product.
    Li X; An Y; Liao J; Xiao L; Swanson M; Martinez-Fonts K; Pavon JA; Sherer EC; Jawa V; Wang F; Gao X; Letarte S; Richardson DD
    Biotechnol Prog; 2021 May; 37(3):e3128. PubMed ID: 33476097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.